HIF1A and peripheral arterial disease: With consideration of the time efficacy of BAY‐87 on HIF‐1α inhibition (3 hr following its administration) and the subsequent beneficial effect on attenuating the exaggerated exercise pressor reflex in the simulated PAD model, it shed light upon the development of the future therapeutic strategy for the clinical PAD patients.